Sunday 29 November 2015
Cervical cancer

Gavi funds cervical cancer immunisation for poor

The Gavi global vaccines group is to help protect more than 180,000 girls in eight countries across Africa and Asia from cervical cancer by funding immunisation projects with vaccines from Merck and GlaxoSmithKline. The non-profit


Cervical cancer vaccines 'very effective'

Using GlaxoSmithKline's  Cervarix vaccine to protect girls against the HPV virus that causes cervical cancer is so effective that health authorities could reduce the need for later cervical screening, scientists said on Wednesday.


US approves Glaxo's cervical cancer shot

GlaxoSmithKline has won US approval to sell a cervical cancer vaccine for girls and young women, while a rival Merck & Co shot was cleared for preventing genital warts in males. Glaxo said the US Food and Drug Administration cleared th

 1 2 3 4 5 >  Last ›

calendarCalendar of Events